{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-009897","form_type":"8-K","ticker":"NUTX","cik":"0001479681","company_name":"Nutex Health Inc.","filed_at":"2023-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.997035+00:00","generated_at":"2026-06-15T01:00:40.409444+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Nutex Health Q1 net loss $5.1M; revenue falls 29% YoY to $56.3M","bullets":["Net loss attributable to Nutex Health of $5.1M ($0.01 EPS) vs net income of $21.4M ($0.04 EPS) in Q1 2022.","Net revenue $56.3M, down 29% from $79.1M; hospital division revenue $49.3M vs $79.1M; population health contributed $7.0M.","Adjusted EBITDA $2.4M; cash from operations $1.1M; cash and equivalents $32.8M at March 31.","Closed three unprofitable Texas facilities in Q1; expects to open 4-5 micro hospitals in 2023 and 14 by end 2025.","Entered $100M prepaid advance with Yorkville (received $12.6M net in April); $100M Lincoln Park Capital commitment unused."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-009897","json":"https://secwatch.observer/filing/0001558370-23-009897.json","markdown":"https://secwatch.observer/filing/0001558370-23-009897.md","text":"https://secwatch.observer/filing/0001558370-23-009897.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1479681/000155837023009897/0001558370-23-009897-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1479681/000155837023009897/nutx-20230515x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T01:00:40.409444+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e15a13f2ed149202555fdb4b59554476155629cd","claim":"Nutex Health Inc. reported first quarter 2023 results: revenue $56.3 million, net income Net loss attributable to Nutex Health of $5.1 million.","evidence_excerpt":"Financial Highlights for the Three Months Ended March 31, 2023: ● Net revenue of $56.3 million. ● Net loss attributable to Nutex Health of $5.1 million.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1479681/000155837023009897/0001558370-23-009897-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter 2023"},{"label":"Revenue","value":"$56.3 million"},{"label":"Net income","value":"Net loss attributable to Nutex Health of $5.1 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}